TCG Crossover GP II, LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:21 pm Sale |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
TCG Crossover GP II, LLC | 2,761,861 4.900% |
-1,607,067 (-36.78%) |
Filing |
| 2024-01-16 4:18 pm Purchase |
2024-01-05 | 13G | Astria Therapeutics, Inc. ATXS |
TCG Crossover GP II, LLC | 4,368,928 9.900% |
4,368,928 (New Position) |
Filing |